Referencias

1. Engel H, Steinert H, Buck A, et al. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996; 37:441-6. PMID: 8772641.
2. Moon SH, Eo JS, Lee JJ, et al. (18)F-FDG uptake of human testis on PET/CT: Correlation with age, sex hormones, and vasectomy. Nucl Med Mol Imaging 2011; 45:291-98. doi:10.1007/s13139-011-0108-6
3. Meller J, Sahlmann C, Scheel AK. 18F-FDG PET and PET / CT in fever of unknown origin. J Nucl Med 2007; 48:35-45.
4. Shao D, Gao Q, Tian XW, et al. Differentiation and diagnosis of benign and malignant testicular lesions using 18F-FDG PET/CT. Eur J Radiol 2017; 93:114-20.
5. Ambrosini V, Zucchini G, Nicolini S, et al. 18F-FDG PET/CT impact on testicular tumours clinical management. Eur J Nucl Med Mol Imaging 2014; 41:668-73.
6. Honecker F, Aparicio J, Berney D, et al. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol 2018; 29:1658-86.
7. Dotzauer R, Thomas C, Jäger W. The use of F-FDG PET/CT in testicular cancer. Transl Androl Urol 2018; 7:875-8. doi:10.21037/tau.2018.09.08.
8. Kosuda S, Fisher S, Kison PV, et al. Uptake of 2-deoxy-2-[18F]fluoro-D-glucose in the normal testis: retrospective PET study and animal experiment. Ann Nucl Med 1997; 11:195-9.
9. Kitajima K, Nakamoto Y, Senda M, et al. Normal uptake of 18F-FDG in the testis: an assessment by PET/CT. Ann Nucl Med 2007; 21:405-10.
10. Harper L, Simmons C, Nathan M, et al. Establishing normal testicular 18F-FDG PET/CT SUVs. Am J Roentgenol 2021; 216:1634-40. doi: 10.2214/AJR.20.23344.
11. Meij-de Vries A, Knol RJ, Lazarenko SV, et al. Uptake of (18)F-fluoro-2-deoxyglucose in the healthy testes of young men as assessed by positron emission tomography/computed tomography: including the inter- and intra-observer variation. World J NuclMed 2014; 13:88-93.